Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study
Open Access
- 28 July 2007
- journal article
- Published by Springer Nature in BMC Clinical Pharmacology
- Vol. 7 (1), 8
- https://doi.org/10.1186/1472-6904-7-8
Abstract
Adverse drug reactions (ADRs) are now recognized as an important cause of hospital admissions, with a proportion ranging from 0.9–7.9%. They also constitute a significant economic burden. We thus aimed at determining the prevalence and the economic burden of ADRs presenting to Medical Emergency Department (ED) of a tertiary referral center in IndiaKeywords
This publication has 17 references indexed in Scilit:
- Readmissions and adverse drug reactions in internal medicine: the economic impactJournal of Internal Medicine, 2004
- Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory SettingJAMA, 2003
- Evaluation of outpatient adverse drug reactions leading to hospitalization.American Journal of Health-System Pharmacy, 2003
- Preventable Drug-Related Hospital AdmissionsAnnals of Pharmacotherapy, 2002
- Adverse drug events in emergency department patientsAnnals of Emergency Medicine, 2002
- A cost-analysis of suspected adverse drug reactions in a hospital emergency wardPharmacoepidemiology and Drug Safety, 1999
- Adverse drug reactions and polypharmacy in the elderly in general practiceEuropean Journal of Clinical Pharmacology, 1999
- Preventability and severity assessment in reporting adverse drug reactionsAmerican Journal of Health-System Pharmacy, 1992
- Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of preventionJournal of Internal Medicine, 1990
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981